Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

16:03 EDT 28th May 2015 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 22,000+

Thursday 28th May 2015

Jury Finds Boston Scientific Liable For Woman's Two Defective Transvaginal Mesh Devices, Says Motley Rice LLC

MT. PLEASANT, S.C., May 28, 2015 /PRNewswire-USNewswire/ -- A Delaware jury today awarded $25 million in compensatory and $75 million in punitive damages to Newark, Delaware, resident Deborah Barba, finding the medical device manufacturer Boston Scientific liable for several permanent and serious injuries caused by its Advantage Fit and Pinnacle transvaginal mesh (TVM) products. Since being implan...

Fairview Health Services Taps Novu for Clinical Pilot Programs Focused on Fighting Diabetes and Smoking Addiction

Novu today announced that Fairview Health Services will launch five clinical pilot programs on the Novu Platform to evaluate the effectiveness and efficiency of augmenting traditional care resources with digital tools, such as rewards, community, challenges, devices and self-management programs. In the initial phase, Fairview will use

ndd Medical Technologies and COPD Foundation Help Fight COPD in Chicago

Free Mobile Respiratory Screening Taking Place during COPD9USA on June 5 ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT), announced that it is partnering with the COPD Foundation during its

GlycoMimetics to Present at the Jefferies 2015 Healthcare Conference

GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that President & Chief Executive Officer Rachel King will present at the Jefferies 2015 Healthcare Conference on Monday, June 1, 2015 from 11:00 – 11:30 a.m. Eastern Time. The conference will take place at The Grand Hyatt, New York City. To access the live webcast and subsequent archived rec...

AACR, Bayer to fund fellowships to advance cancer research

The American Association for Cancer Research (AACR) and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.

Rosetta Genomics Launches OncoGxOne™

Leverages Admera Health’s industry-leading, next-generation sequencing technology Provides oncologists with unique solution of cutting-edge comprehensive genomic and microRNA profiling to optimize therapeutic decision-making Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics,...

Health Highlights: May 28, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Cancer-Spreading Hysterectomy Device Focus of FBI Investigation A hysterectomy device found to spread uterine cancer is the focus of an FBI...

aParent IVF Performs New Techniques In Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) Giving Couples Trying to Conceive a Viable Option For a Healthy Baby

Becoming a parent can be a stressful decision for people with a history of inheritable genetic disorders or chromosomal defects, especially if they already have a child with these problems. Likewise, if a woman has a history of recurrent miscarriages or if a mother is over the age of 35 or 40, which increase the risk of having a child with Down syndrome. ...

Team discovers key step in how taste buds regenerate

Researchers at the University of Colorado Anschutz Medical Campus have discovered a key molecular pathway that aids in the renewal of taste buds, a finding that may help cancer patients suffering from an altered sense of taste during treatment.

Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate (ADC) Programs at ASCO Annual Meeting

Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that data from multiple proprietary and collaborator antibody-drug conjugate (ADC) programs will be highlighted in more than 10 sessions at the American Society of Clinical Oncology (ASCO) 2015 Annual Meeting being held May 29 to June 2, 2015 in

Altor BioScience Announces Upcoming Data Presentation on Efficacy and Safety of ALT-801 for Advanced Bladder Cancer at 2015 ASCO Annual Meeting

Altor BioScience Corporation (Altor), a leading developer of cancer immunotherapies, announced today that it will present updated safety and efficacy data from its ongoing Phase 1b/2 study of ALT-801 in combination with gemcitabine and cisplatin in patients with advanced or metastatic chemo-refractory urothelial cancer. The data will be presented in Poster...

Fluxion Biosciences and Swift Biosciences Announce Jointly Developed Next-Generation Sequencing Workflow for Somatic Mutation Detection From Liquid Biopsy Samples

In advance of the 2015 American Society of Clinical Oncology Annual meeting, Fluxion Biosciences, Inc. and Swift Biosciences, Inc. announced a new workflow for oncology clinical research designed to detect somatic mutations from a routine blood draw. The jointly-developed workflow utilizes Fluxion’s IsoFlux™ System for circulating tumor cell (CTC) enri...

Hearst Editorial Director Ellen Levine & Author Lee Woodruff To Speak At The Brain & Behavior Research Foundation's "Women Breaking The Silence About Mental Illness" Luncheon

NEW YORK, May 28, 2015 /PRNewswire-USNewswire/ -- The Brain & Behavior Research Foundation, a not-for-profit organization funding innovative scientific research to better understand the causes, develop new treatments for, and alleviate suffering from brain and behavior disorders, will host its second "Women Breaking the Silence About Mental Illness" Luncheon featuring a discussion between...

US guideline may have led to drop in PSA testing among primary care physicians, studies find

The controversial US Preventive Services Task Force (USPSTF) guidelines that recommended against routine prostate cancer screening with the prostate specific antigen (PSA) test may be changing the...

Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read

Madison, Wisconsin (PRWEB) May 28, 2015 The Cancer Solution: Taking Charge of Your Life with Cancer is hands-down the most rewarding, researched and heartfelt book the Booksandauthor reviewer ever read about the subject. The reviewer thanked ...

The Top Businesswomen In The Cannabis Industry

Here are some of the top business women in the marijuana industry.

BRIEF-Bayer, J&J to study Xarelto for pulmonary embolism, DVT in cancer patients

* And partner J&J say to initiate study to explore xarelto in prevention and treatment of pulmonary embolism and deep vein thrombosis in cancer patients Further company coverage:

Pfizer Announces $3 Million Grants Program to Further Clinical Research in Advanced Breast Cancer

Pfizer Inc. today announced the launch of a competitive, peer-reviewed grants program to support clinical research projects investigating IBRANCE® (palbociclib) in advanced breast cancer. The multi-year program, which will award a total of up to $3 million in grants to investigators in the United States, is an extension of Pfizer’s Advancing Science thr...

Merck and NanoString Announce Clinical Research Collaboration to Develop an Immune-Related Gene Expression Assay for Use in the Development Program for KEYTRUDA® (pembrolizumab)

Collaboration Builds on Merck’s R&D and NanoString’s Biomarker Development Leadership Positions in Immuno-Oncology Early Data Evaluating Immune-Related Signatures with KEYTRUDA in Multiple Cancers to be Presented for the First Time at 2015 ASCO Annual Meeting Merck (NYSE:MRK), known as MSD outside the United States and Canada, and ...

Cavion to Present Clinical Trial Data at ASCO

Enrollment Complete in Phase 1 Study of Mibefradil in Patients with Recurrent High-Grade Glioma Receiving Temozolomide Retreatment Cavion LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors and neurologic diseases, announced today that Matthias Holdhoff, MD, PhD of the Sidney Kimmel Comprehensive...

OncoBreak: Squeeze on Research $$$, Still So Many Die, Immunity Unleashed

(MedPage Today) -- News, features, and commentary about issues related to cancer.

Raze Therapeutics Announces Addition of Robert Copeland, PhD, to Scientific Advisory Board

Raze Therapeutics, a leading next-generation cancer metabolism company, announced today the addition of Robert Copeland, PhD, President of Research and Chief Scientific Officer at Epizyme, Inc., to its Scientific Advisory Board (SAB). Dr. Copeland brings deep experience in oncology drug discovery and development to Raze’s SAB. Dr. Copelan...

Castle Biosciences Expands Sales Force and Appoints Patrick Hall as Executive Director of Medical Affairs, Promotes Robert W. Cook to Executive Director, R&D

Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment, today appointed Patrick Hall, D.Ph., to the newly created role of Executive Director, Medical Affairs and announced the promotion of Robert W. Cook, Ph.D. The Company also announced the expansion of its sales force to meet the increasing demand among dermatologists, ...

Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) Highlighted in Four Abstracts for Presentation at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting

The Multiple Myeloma Research Foundation (MMRF) and its affiliate organization and clinical research network, the Multiple Myeloma Research Consortium (MMRC), will be highlighted in four oral and/or poster presentations from their research and development collaborations with academia and industry at the 2015 American Society of Clinical Oncology (ASCO) ann...

National Survey Reveals that Rosacea Sufferers Often Hide Behind Cosmetics Before Treating the Condition

Galderma Laboratories, L.P. and The National Rosacea Society Launch “Break Up with Your Makeup” to Clarify Common Rosacea Misconceptions and Empower Those Impacted to Take Action Galderma Laboratories, L.P., and the National Rosacea Society (NRS) today announced the launch of Break Up with Your Makeup, an educational campaign and contest to empower...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks